Back to search
FDAFDA · Food and drugs·Recall number Z-1696-2023

Alinity i Anti-TPO Reagent Kit, List Number 09P3521

Published June 14, 2023 · Recall initiated: April 24, 2023

Summary

FDA records medical device Class III recall Z-1696-2023, published June 14, 2023 and initiated April 24, 2023. Recalling firm: Abbott Ireland Limited; Status: Ongoing; Reported quantity: 110 kits; Lot: UDI Number: (01)00380740153892(17)240720(10)46009FN00; List Number: 09P3521; Lot Number: 46009FN00; Expiration Date: 07/20/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to a manufacturing fill volume error, Alinity i Anti-TPO Reagent contains a marginally lower fill volume than detailed in the Kit Contents section of the Instructions for Use (IFU).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abbott Ireland Limited
Distributor
US Nationwide distribution in the states of CA, CO, FL, GA, IL, KY, LA, MD, MI, MN, NJ, NY, OH, RI, SC, SD, TN, TX, WA. No international distribution of affected lot.
Lot
UDI Number: (01)00380740153892(17)240720(10)46009FN00; List Number: 09P3521; Lot Number: 46009FN00; Expiration Date: 07/20/2024
Risk classification
Class III
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Alinity i Anti-TPO Reagent Kit, List Number 09P3521 recalled?

Yes. FDA published recall Z-1696-2023 on June 14, 2023. Reported hazard: Due to a manufacturing fill volume error, Alinity i Anti-TPO Reagent contains a marginally lower fill volume than detailed in the Kit Contents section of the Instructions for Use (IFU).

What should I do if I have this product?

Voluntary: Firm initiated · Letter